DraftKings Stock Gains As JPMorgan Upgrades The Co.

Shares of DraftKings Inc. (DKNG) are gaining nearly 3% after analysts at JPMorgan Chase & Co. upgraded the stock.

DKNG is currently trading at $28.17, up $0.81 or 2.96%, on the Nasdaq. The stock opened its trading at 28.50 after closing Monday’s trading at $27.36. The stock has traded between $10.69 and $34.49 in the past 52-week period.

DraftKings was upgraded by analysts at JPMorgan Chase & Co. from a “neutral” rating to an “overweight” rating. The price target was also increased from $26.00 to $37.00.

Canopy Growth Gains 7%

Shares of the diversified cannabis company Canopy Growth Corp. (CGC) are gaining more than 7 percent on Tuesday morning trade.

The company announced that at the AGM, a total of 350,593,653 common shares, representing 48.88 percent of the issued and outstanding shares, were voted in connection with the meeting by the Company’s shareholders and proxy holders.

Canopy’s shareholders approved the adoption of its new equity incentive plan, the amendment to consolidate to its issued and outstanding shares.

AGM also approved the issuance of shares pursuant to certain outstanding convertible debentures in an amount that is in excess of 19.99% and 25%.

Currently, shares are at $1.00, up 7.01 percent from the previous close of 30,576,652.

I'm an EV driver – now I understand why people don't like electric cars… here's three reasons I hate mine | The Sun

AN EXPERT has identified three key features that could put buyers off an electric vehicle.

A review by an expert of the American RIvian R1S revealed three key points which could deter buyers from considering an electric vehicle (EV.)

The first point identified was the fact that the new owner might forget to charge their new car at night, meaning the battery will run low. This could cause the car to stop when out on the road.

The second issue was that the EV features regenerative breaking. This is a feature where the car starts to automatically slow down after the driver takes their foot off the accelerator.

The reviewer admits that many drivers might struggle a bit with this.

The third potential stumbling block was the fact that the driver uses their phone as an ignition key.

He states that this takes a bit of getting used to.The Californian made RIvian R1Sis a big fast all electric SUV pitched at drivers who want to go off road for day trips or camping holidays.

Bullfrog AI Stock Jumps On Positive Data From Preclinical Study Of Brain Cancer Treatment

Shares of Bullfrog AI Holdings, Inc. (BFRG) jumped over 24% on Tuesday morning after the company announced positive data from preclinical study evaluating prodrug of mebendazole for treatment of glioblastoma.

BFRG is currently trading at $3.5697, up $0.6997 or 24.3798%, on the Nasdaq. The stock opened its trading at $3.1200 after closing Monday’s trading at $2.8700. The stock has traded between $2.4700 and $9.5000 in the past 52-week period.

BullFrog AI announced positive data in a preclinical study investigating the anti-cancer activity of a novel prodrug of mebendazole for the treatment of glioblastoma.

The study assessed the relative efficacy of BF-222, a novel formulation of mebendazole that has been evaluated in clinical trials, and BF-223, a novel prodrug of mebendazole with improved solubility and bioavailability relative to BF-222, compared with placebo in mice that had been implanted with tumor cells as a model for human glioblastoma.

Americans To Get Rapid Antigen Test Kits For Free

With the reopening of the Biden administration’s at-home testing program, every U.S. household can place an order to receive four free Covid-?19 rapid tests delivered directly to their home.

The free antigen test kits an be ordered through COVIDtests.gov.

The tests will detect a new variant of the virus, which is currently circulating in many states.

The kits are intended for use through the end of 2023. It will include instructions on how to verify extended expiration dates. Many kits have had their expiration dates extended beyond what may be printed on the packaging.

The Federal Trade Commission said that the recipients don’t have to pay for shipping, and they will never be asked for a credit card or bank account number. “You only need to give a name and shipping address. If you’d like an email confirmation and delivery updates from the U.S. Postal Service, you can submit your email address”.

FTC warned that anyone who asks for more information than that is a scammer.

A spike in U.S. Covid hospitalizations has been reported by the Centers for Disease Control and Prevention in the last few weeks.

The free at-home Covid-19 testing service had been suspended earlier this year to conserve supplies.

Verve Up 19% On Report To Unveil Clinical Trial Data Of VERVE-101 At AHA's Event

Verve Therapeutics, Inc. (VERV) saw a 19% increase in shares on Tuesday following their announcement of presenting interim data from their heart-1 Phase 1b clinical trial of VERVE-101 in HeFH patients at the American Heart Association’s (AHA) Scientific Sessions 2023 in November.

VERV is trading on the Nasdaq at $13.69, up 19.88% or $2.27 per share. It has traded between $11.25 and $40.88 in the past 52-week period.

The company stated that it expects to report initial safety and pharmacodynamic data, as well as blood PCSK9 and blood LDL-C levels, from patients across four SAD cohorts.

The heart-1 Phase 1b clinical trial aims to evaluate the safety and tolerability of VERVE-101 in single ascending dose (SAD) cohorts of the highest-risk patients with HeFH, established ASCVD, and uncontrolled LDL-C levels on oral standard-of-care therapy.